Amgen to respond to senator inquiry
From Times Staff and Wire Reports
Amgen Inc. said it would cooperate with an inquiry from Sen. Charles E. Grassley (R-Iowa) into whether the company failed to provide the Food and Drug Administration with data from safety studies of its top-selling anemia drugs.
